Planet Labs
PL
$15.96
-7.10%
Planet Labs PBC is an Earth-imaging company that operates the world's largest fleet of commercial imaging satellites, delivering daily imagery, analytics, and machine-learning-derived insights through products including Planet Monitoring, Planet Tasking, Planetary Variables, and Analytic Feeds to customers spanning defense and intelligence, civil government, agriculture, forestry, energy, and maritime end markets. As a first-mover in high-cadence global monitoring, Planet occupies a distinct niche as a data-and-platform provider rather than a pure hardware or launch company, positioning it as critical infrastructure for governments and enterprises that need persistent visibility of a changing planet. The current investor narrative is dominated by extreme volatility: shares surged in spring 2026 on SpaceX IPO-driven sector euphoria and a landmark U.S. national-security data partnership, then collapsed roughly 60% from May highs after a dilutive equity offering and unmet sky-high expectations, with the stock now caught between a bullish long-term defense-and-intelligence growth story and near-term skepticism about cash burn, dilution, and the sustainability of its premium valuation. Sentiment remains bifurcated, with sell-side analysts maintaining a consensus Buy rating even as the share price sits near the bottom of its 52-week range, reflecting a market that is pricing in substantial execution risk despite the company's improving revenue trajectory.…
PL
Planet Labs
$15.96
Related headlines
Investment Opinion: Should I buy PL Today?
Based on the synthesis of data, the recommendation is a Hold with a speculative bias. The core thesis is that Planet Labs is a high-growth, early-stage company with a unique position in Earth observation, but its extreme valuation and ongoing losses warrant caution until profitability is consistently demonstrated. The analyst consensus is Buy with an average target of $31.91, implying 85.7% upside, but the wide target range ($17-$50) and recent downgrades to Hold by some firms suggest limited near-term conviction.
Supporting evidence includes: 1) Revenue growth of 58.14% YoY in Q2 FY2027, far exceeding sector averages; 2) Gross margin expansion to 56.55%, indicating pricing power and scale; 3) Positive free cash flow of $25.60M in Q2, a critical milestone; 4) Analyst average target of $31.91, 85.7% above the current price. However, the PS ratio of 24.98x is significantly above the sector, and the company remains unprofitable with a net margin of -8.06%. The balance sheet shows $423.63M in cash, providing a buffer, but debt-to-equity of 2.45 is high.
The biggest risks that could invalidate the thesis are: 1) Revenue growth decelerating below 30% YoY, which would make the premium valuation untenable; 2) Continued cash burn requiring further dilutive financing; 3) Competitive pressures eroding market share. The rating would upgrade to Buy if the company achieves sustained profitability (e.g., positive net income for two consecutive quarters) and PS compresses below 15x. It would downgrade to Sell if revenue growth falls below 20% or if cash burn accelerates, leading to a breach of the $10.52 low. Relative to its history, the stock is undervalued (PS 24.98x vs. historical high of 135.68x), but relative to peers, it is overvalued. The valuation verdict is that PL is fairly valued for its growth prospects but carries high risk.
Sign up to view all
PL 12-Month Price Forecast
Planet Labs presents a high-risk, high-reward opportunity. The company's accelerating revenue growth and improving margins are compelling, but the extreme valuation and lack of profitability warrant caution. The stock's recent 67% drawdown reflects a repricing of growth expectations, and while the analyst consensus remains bullish, the wide target range and recent downgrades to Hold indicate uncertainty. I would upgrade to bullish if the company reports positive net income and sustains >40% revenue growth for two consecutive quarters. I would downgrade to bearish if revenue growth falls below 20% or if another dilutive equity offering occurs. Given the current data, a neutral stance is appropriate, with a bias toward waiting for a confirmed technical bottom or fundamental inflection before committing.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Planet Labs's 12-month outlook, with a consensus price target around $31.73 and implied upside of +98.8% versus the current price.
Average Target
$31.73
0 analysts
Implied Upside
+98.8%
vs. current price
Analyst Count
—
covering this stock
Price Range
$17 - $50
Analyst target range
Planet Labs is covered by 11 analysts, with a consensus recommendation of "Buy" (recommendation mean of 1.92 on a scale where 1 is Strong Buy and 5 is Strong Sell), indicating a moderately bullish tilt. The average price target of $31.91 implies substantial upside of approximately 85.7% from the current price of $17.18, a striking disconnect that reflects either significant undervaluation or stale targets that have not yet been revised downward following the recent collapse. The consensus leans bullish, with recent institutional ratings showing persistent Buy/Outperform ratings from Needham, Wedbush, Craig-Hallum, and Citigroup, while Citizens and Goldman Sachs maintain more cautious Market Perform/Neutral stances — a split that captures the debate between the long-term growth story and near-term execution and dilution concerns. The target range is extraordinarily wide, spanning from a low of $17.00 to a high of $50.00 — a spread of $33.00, or nearly 194% of the current share price — which signals very high uncertainty and low conviction among analysts. The high target of $50.00 implies a scenario of sustained hyper-growth, successful conversion of the defense-and-intelligence pipeline into recurring revenue, margin expansion toward profitability, and multiple expansion back toward the euphoric levels seen in May 2026; it essentially assumes the market re-rates the stock back to its prior peak. The low target of $17.00 — essentially the current price — prices in a scenario of continued cash burn, further dilution, competitive pressure from larger satellite operators, and a market that refuses to pay a premium for unprofitable growth. Notably, the low target sitting at the current price suggests the most bearish analyst sees no upside, while the average target of $31.91 is 85.7% above the low target, underscoring the absence of consensus on fair value. The recent ratings actions show no downgrades but also no upgrades since June 2026, with firms holding steady positions — a pattern suggesting analysts are waiting for evidence of either a fundamental turnaround or further deterioration before adjusting their views, and the wide target spread combined with the stock's beta of 2.17 means investors should expect continued high volatility as the market searches for a new equilibrium.
Bulls vs Bears: PL Investment Factors
The bull case rests on accelerating revenue growth (58% YoY), expanding gross margins (56.55%), and a clear path to profitability, supported by a Buy consensus and 85.7% upside to average targets. The bear case highlights an extreme valuation (PS 24.98x), persistent losses, dilution, and a brutal downtrend that has erased 67% from May highs. Currently, the bear evidence appears stronger in the near term due to technical breakdown and valuation risk, but the bull case gains traction if revenue growth sustains and profitability is achieved. The single most important tension is whether Planet can convert its hyper-growth into sustainable profits without further dilutive financing; if it does, the stock could re-rate significantly, but failure would likely lead to a retest of the 52-week low.
Bullish
- Revenue growth accelerating sharply: Q2 FY2027 revenue of $116.05M grew 58.14% YoY, up from $73.39M in the prior-year quarter. This marks a dramatic acceleration from the ~15% growth in Q2 FY2026 and extends a multi-quarter uptrend, signaling strong demand for Planet's data and analytics.
- Gross margins expanding: Gross margin reached 56.55% in Q2 FY2027, up from 53.53% in Q1 FY2027 and 54.17% in Q4 FY2026. This expansion, combined with revenue growth, indicates improving unit economics and operating leverage.
- Path to profitability emerging: Net loss narrowed to $9.35M in Q2 FY2027 from $138.87M in Q1 FY2027 and $152.46M in Q4 FY2026, with operating income improving to -$13.51M from -$34.89M. The company generated $25.60M in free cash flow in Q2, demonstrating progress toward sustainable profitability.
- Strong analyst consensus and upside: 11 analysts rate PL a Buy (mean 1.92) with an average target of $31.91, implying 85.7% upside from $17.18. The high target of $50 suggests significant long-term potential if execution continues.
Bearish
- Extreme valuation premium: PL trades at a PS of 24.98x and EV/Sales of 15.57x, far above the Aerospace & Defense sector's typical low-to-mid single-digit multiples. The PB ratio of 40.79x is extraordinarily elevated, leaving little margin for error.
- Persistent unprofitability and cash burn: Despite improving, the company remains unprofitable with a net margin of -8.06% and operating margin of -11.64% in Q2 FY2027. TTM free cash flow is only $23.43M, and reliance on external financing ($122.50M equity issued in Q2) dilutes shareholders.
- Severe stock downtrend and volatility: PL is down 50.45% over six months and 34.05% over three months, with a beta of 2.17 and max drawdown of 68.83%. The stock sits at just 16.1% of its 52-week range, reflecting deep pessimism and momentum breakdown.
- Dilution risk from equity offerings: The company issued $122.50M in common stock in Q2 FY2027 and $135.08M in Q4 FY2026, increasing shares outstanding from 304M to 359M. Further dilution is likely if cash burn continues, pressuring per-share value.
PL Technical Analysis
Planet Labs is in a pronounced downtrend that has erased most of its prior-year gains, with the stock up just 9.71% over the trailing twelve months but down 50.45% over six months and 34.05% over three months. At a current price of $17.18, the shares sit at approximately 16.1% of the 52-week range between a low of $10.52 and a high of $51.76 — a positioning that signals deep pessimism and potential capitulation rather than momentum, though it also raises the risk of catching a falling knife given the absence of a confirmed base. The magnitude of the decline from the May peak near $51.40 to current levels represents a drawdown of roughly 67%, underscoring how violently the market has repriced the space sector's growth expectations. Recent momentum remains decisively negative and is diverging sharply from the longer-term trend: the stock is down 23.23% over the past month versus a 2.12% gain for the S&P 500, producing a relative strength reading of -2.35, while the three-month relative strength of -37.18 and six-month reading of -65.04 reveal persistent and severe underperformance against the broader market. This divergence — a positive 1-year return masking a brutal 3- and 6-month collapse — suggests the rally was sentiment-driven and unsustainable, and the current price action reflects a mean-reversion process that has not yet found a durable floor; the 1-month decline of 23.23% accelerating after the 3-month decline of 34.05% indicates momentum is still deteriorating rather than stabilizing. Key technical levels are well-defined: the 52-week low at $10.52 serves as the critical support zone, roughly 39% below the current price, while the 52-week high at $51.76 represents formidable resistance some 201% above current levels, with intermediate resistance likely forming around the $20-$22 area where the stock consolidated in late July and August. A breakdown below the $16.00-$16.50 area — which has held as a floor through September and early October — would open the door to a retest of the 52-week low, whereas a breakout above $22 would be the first meaningful signal of trend reversal. With a beta of 2.17, Planet Labs is more than twice as volatile as the broader market, meaning a 1% move in the S&P 500 has historically corresponded to a 2.17% move in PL; this amplifies both downside risk in the current downtrend and upside potential in any recovery, and demands careful position sizing given the stock's maximum drawdown of 68.83%.
Beta
2.17
2.17x market volatility
Max Drawdown
-69.0%
Largest decline past year
52-Week Range
$11-$52
Price range past year
Annual Return
+8.6%
Cumulative gain past year
| Period | PL Return | S&P 500 |
|---|---|---|
| 1m | -3.0% | +1.8% |
| 3m | -37.6% | +3.5% |
| 6m | -53.6% | +11.2% |
| 1y | +8.6% | +19.1% |
| ytd | -21.8% | +14.1% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
PL Fundamental Analysis
Planet Labs' revenue trajectory is genuinely accelerating, with the most recent quarter (ending July 31, 2026) delivering $116.05 million in revenue, a 58.14% year-over-year increase from the $73.39 million reported in the same quarter a year earlier. This marks a dramatic inflection from the prior-year period, when quarterly revenue was growing at a much slower pace, and extends a multi-quarter uptrend: revenue rose from $81.25 million in Q3 FY2026 to $86.82 million in Q4 FY2026 to $94.15 million in Q1 FY2027 before reaching $116.05 million in Q2 FY2027. The sequential acceleration — including a notable jump from $94.15 million to $116.05 million — suggests the company is benefiting from large government and defense contracts, and the single reportable segment structure means the growth is broad-based rather than driven by a single product line. If this pace is sustained, it materially strengthens the investment case, though the market's skepticism centers on whether such growth is repeatable or reflects lumpy, contract-timing-driven revenue. Profitability remains the central concern: while gross margin is a healthy 56.55% in the latest quarter (up from 53.53% in Q1 FY2027 and 54.17% in Q4 FY2026), the company is still unprofitable, posting a net loss of $9.35 million in Q2 FY2027 and a net margin of -8.06%. The encouraging trend is that losses are narrowing dramatically — from -$152.46 million in Q4 FY2026 and -$138.87 million in Q1 FY2027 to just -$9.35 million in Q2 FY2027 — with the Q1 FY2027 loss heavily distorted by a $102.97 million non-cash other-expense item. Operating income remains negative at -$13.51 million (a -11.64% operating margin), but the improvement from -$34.89 million in Q1 FY2027 and -$36.00 million in Q4 FY2026 shows operating leverage beginning to materialize as revenue scales against a relatively fixed cost base, with R&D at $35.16 million and SG&A at $43.99 million in the latest quarter. The balance sheet presents a mixed picture: the debt-to-equity ratio of 2.45 is elevated and reflects the company's capital structure, while the current ratio of 1.65 indicates adequate short-term liquidity. Positively, the company generated $52.95 million in operating cash flow and $25.60 million in free cash flow in Q2 FY2027, with trailing-twelve-month free cash flow of $23.43 million, and it holds $423.63 million in cash at period end — a substantial buffer. However, the company has been reliant on external financing, issuing $122.50 million in common stock in Q2 FY2027 and $135.08 million in Q4 FY2026, which is dilutive to existing shareholders; ROE of -131.01% and ROA of -5.05% underscore the current lack of capital efficiency, though the improving FCF profile suggests the funding need may diminish if profitability continues to improve.
Quarterly Revenue
$116052000.0B
2026-07
Revenue YoY Growth
+58.1%
YoY Comparison
Gross Margin
56.5%
Latest Quarter
Free Cash Flow
$23431000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is PL Overvalued?
Because Planet Labs reported negative net income (EPS of -$0.03 and trailing net margin of -80.22%), the PE ratio is not meaningful — the trailing PE of -31.21 and forward PE of -13,744.00 are artifacts of near-zero or negative earnings and cannot be used for valuation. I therefore selected the price-to-sales (PS) ratio as the primary metric, which stands at 24.98x trailing, alongside an EV/Sales of 15.57x; the gap between the PS and EV/Sales multiples reflects the company's net cash position. The forward PE of -13,744.00 is technically meaningless but implies the market expects earnings to approach breakeven, and the analyst consensus EPS estimate of $0.25 for the coming year suggests the company is projected to cross into profitability — a critical inflection that would fundamentally change the valuation framework if achieved. Relative to the Aerospace & Defense sector, Planet Labs trades at a massive premium: a PS of 24.98x and EV/Sales of 15.57x are far above typical defense-sector multiples in the low-to-mid single digits, and the PB ratio of 40.79x is extraordinarily elevated. This premium is partially justified by the company's 58.14% revenue growth rate — far exceeding the mid-single-digit growth typical of established aerospace and defense primes — but the magnitude of the premium leaves little margin for error, and the negative net margin of -80.22% and operating margin of -30.90% mean the company is being valued almost entirely on future potential rather than current profitability. The premium would only be defensible if Planet sustains hyper-growth and achieves meaningful margin expansion toward the 56.55% gross margin level flowing through to the bottom line. Historically, Planet Labs' valuation has been extraordinarily volatile: the PS ratio ranged from a low of 8.06x in Q1 FY2025 (April 2024) to a high of 135.68x in Q1 FY2027 (April 2026), with the current 24.98x sitting in the lower-middle portion of that range but still well above the 2024 trough. The PB ratio tells a similar story, having ranged from 0.97x in Q1 FY2025 to 42.06x in Q4 FY2026 before settling at 40.79x currently — near the top of its historical band despite the price collapse, because book value has been eroded by accumulated losses. This suggests the market is still pricing in optimistic recovery expectations even after the 67% drawdown, and the stock is not yet at the deep-value levels seen in 2024; investors should recognize that the current valuation embeds a successful execution scenario and offers limited downside protection if growth disappoints.
PE
-31.2x
Latest Quarter
vs. Historical
N/A
5-Year PE Range 17x~59x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
-40.2x
Enterprise Value Multiple
Investment Risk Disclosure
Planet Labs faces significant financial and operational risks. The company is unprofitable, with a net margin of -8.06% and operating margin of -11.64% in Q2 FY2027, despite revenue growth. Cash burn remains a concern, though free cash flow turned positive at $25.60M in Q2, TTM FCF is only $23.43M. The debt-to-equity ratio of 2.45 is elevated, and the company has relied on equity offerings, issuing $122.50M in Q2 FY2027, which dilutes existing shareholders. Revenue concentration in government and defense contracts adds lumpiness risk, as these contracts can be delayed or canceled. Additionally, the company's ROE of -131.01% and ROA of -5.05% highlight poor capital efficiency, and further losses could erode book value, making the 40.79x PB ratio unsustainable.
Market and competitive risks are pronounced. PL trades at a massive premium to peers, with a PS of 24.98x and EV/Sales of 15.57x, versus typical defense-sector multiples in the low-to-mid single digits. This premium is vulnerable to compression if growth decelerates or profitability lags. The stock's beta of 2.17 means it is more than twice as volatile as the market, amplifying downside in a selloff. Competitive threats from larger satellite operators and new entrants like HawkEye 360 could pressure pricing and market share. Recent news highlights sector-wide volatility, with SpaceX IPO fatigue triggering a broad selloff in space stocks, and a government-ordered halt of Planet's data (though viewed as bullish) underscores regulatory and geopolitical risks. Macro sensitivity is high, as rising interest rates could further compress growth stock multiples.
The worst-case scenario involves a combination of slowing revenue growth, continued cash burn, and further dilution, leading to a breakdown below the $16 support level and a retest of the 52-week low of $10.52. From the current price of $17.18, that represents a decline of approximately 38.8%. If the company fails to achieve profitability and analysts downgrade the stock, the bear-case target of $17 (current price) could be breached, and the stock could fall to the 52-week low or lower. The maximum drawdown of 68.83% from the peak illustrates the potential severity. Investors could lose over 35% in this adverse scenario, and given the high beta, losses could be amplified in a market downturn.
FAQ
The key risks include: 1) Financial risk: The company is unprofitable with a net margin of -8.06% and has a high debt-to-equity ratio of 2.45; further cash burn could lead to dilutive financing. 2) Competitive risk: Larger satellite operators and new entrants like HawkEye 360 could pressure pricing and market share. 3) Macro risk: With a beta of 2.17, PL is highly sensitive to market downturns and interest rate hikes, which could compress growth stock multiples. 4) Company-specific risk: Revenue is concentrated in government contracts, which can be lumpy and subject to political changes. The most severe risk is a combination of slowing growth and continued losses, which could drive the stock to the 52-week low of $10.52.
The 12-month forecast has three scenarios: Bull case (25% probability) targets $35-$50, assuming sustained >50% revenue growth and profitability; Base case (50% probability) targets $22-$32, assuming 30-40% growth and narrowing losses; Bear case (25% probability) targets $10-$17, assuming growth decelerates below 20% and cash burn resumes. The base case is most likely, with the stock trading around the analyst average target of $31.91 if growth moderates but remains strong. The key assumption is that revenue growth stays above 30% and the company avoids further dilution.
PL appears overvalued relative to its peers and fundamentals. The PS ratio of 24.98x and EV/Sales of 15.57x are far above the Aerospace & Defense sector's typical low-to-mid single-digit multiples. The PB ratio of 40.79x is also extremely high. However, relative to its own history, the PS ratio is below the peak of 135.68x seen in Q1 FY2027, suggesting the stock is not as overvalued as it once was. The valuation implies the market expects continued hyper-growth and eventual profitability; if those expectations are not met, the stock could face further downside.
PL is a high-risk, high-reward stock that may be suitable for speculative investors. The analyst consensus is Buy with an average target of $31.91, implying 85.7% upside, but the stock trades at a premium valuation (PS 24.98x) and remains unprofitable. The biggest downside risk is a retest of the 52-week low of $10.52, representing a 38.8% decline. For investors with a high risk tolerance and a long-term horizon, PL could be a good buy on dips, but it is not suitable for conservative portfolios. The company's growth trajectory is impressive, but execution risks and dilution concerns persist.
PL is more suitable for long-term investment (3-5 years) for investors who believe in the Earth observation market and can tolerate volatility. The company is in a growth phase, with revenue expanding rapidly but profitability still years away. The stock's high beta (2.17) and lack of dividend make it unsuitable for short-term trading unless one is a momentum trader. Given the recent downtrend, a long-term investor could accumulate on weakness, but a minimum holding period of 2-3 years is recommended to allow for potential profitability and market re-rating. Short-term traders should be aware of the high volatility and potential for further downside.